Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.005 | 0.0412 | 0.0167 |
Echinococcus multilocularis | c Jun NH2 terminal kinase | 0.0466 | 0.6801 | 0.6719 |
Echinococcus granulosus | c-Jun N-terminal kinases | 0.0466 | 0.6801 | 0.6719 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0675 | 1 | 1 |
Echinococcus granulosus | phosphatidylinositol 45 bisphosphate 3 kinase | 0.0184 | 0.247 | 0.2277 |
Mycobacterium leprae | conserved hypothetical protein | 0.0039 | 0.025 | 0.5 |
Echinococcus granulosus | mitogen activated protein kinase | 0.0675 | 1 | 1 |
Loa Loa (eye worm) | CMGC/MAPK/JNK protein kinase | 0.0466 | 0.6801 | 0.6766 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0675 | 1 | 1 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.0043 | 0.0314 | 0.1637 |
Trypanosoma brucei | protein kinase, putative | 0.0675 | 1 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.005 | 0.0412 | 0.0167 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.0412 | 0.0265 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.0412 | 0.0265 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0039 | 0.025 | 0.01 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0675 | 1 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0039 | 0.025 | 0.5 |
Loa Loa (eye worm) | beta-lactamase | 0.0039 | 0.025 | 0.0145 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0039 | 0.025 | 0.5 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0039 | 0.025 | 0.01 |
Echinococcus multilocularis | phosphatidylinositol 4 phosphate 3 kinase C2 | 0.0063 | 0.0621 | 0.038 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.0675 | 1 | 1 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0675 | 1 | 1 |
Brugia malayi | beta-lactamase | 0.0039 | 0.025 | 0.01 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase 2, putative | 0.0098 | 0.1149 | 0.1053 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0039 | 0.025 | 0.01 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase catalytic subunit alpha, beta, delta, putative | 0.0067 | 0.0679 | 0.0536 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0098 | 0.1149 | 0.1013 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0675 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0675 | 1 | 1 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.0098 | 0.1149 | 1 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.0675 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0466 | 0.6801 | 0.6752 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0039 | 0.025 | 0.0145 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.025 | 0.3485 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0039 | 0.025 | 0.0145 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0039 | 0.025 | 0.01 |
Mycobacterium ulcerans | hypothetical protein | 0.0039 | 0.025 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.0412 | 0.0265 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.025 | 0.0145 |
Echinococcus multilocularis | phosphatidylinositol 4,5 bisphosphate 3 kinase | 0.0184 | 0.247 | 0.2277 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 0.0621 | 0.052 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.0078 | 0.0843 | 0.6931 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0039 | 0.025 | 0.01 |
Brugia malayi | Stress-activated protein kinase jnk-1 | 0.0466 | 0.6801 | 0.6752 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.0675 | 1 | 1 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.0675 | 1 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.005 | 0.0412 | 0.0265 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase vps34-like | 0.0033 | 0.0151 | 0.0045 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0039 | 0.025 | 0.0145 |
Onchocerca volvulus | 0.0039 | 0.025 | 0.5 | |
Entamoeba histolytica | phosphatidylinositol 3-kinase 1, putative | 0.0095 | 0.1104 | 0.9555 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.0675 | 1 | 1 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.0675 | 1 | 1 |
Mycobacterium ulcerans | beta-lactamase | 0.0039 | 0.025 | 0.5 |
Mycobacterium leprae | Probable lipase LipE | 0.0039 | 0.025 | 0.5 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0039 | 0.025 | 0.5 |
Trichomonas vaginalis | esterase, putative | 0.0039 | 0.025 | 0.01 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0063 | 0.0621 | 0.0477 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.025 | 0.0145 |
Mycobacterium ulcerans | lipase LipD | 0.0039 | 0.025 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.025 | 0.0145 |
Brugia malayi | beta-lactamase family protein | 0.0039 | 0.025 | 0.01 |
Schistosoma mansoni | phosphatidylinositol-45-bisphosphate 3-kinase catalytic subunit alpha PI3K | 0.0184 | 0.247 | 0.2354 |
Onchocerca volvulus | 0.0039 | 0.025 | 0.5 | |
Trichomonas vaginalis | phosphatidylinositol 3-kinase class, putative | 0.0067 | 0.0679 | 0.0536 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0039 | 0.025 | 0.01 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase catalytic subunit gamma, putative | 0.0098 | 0.1149 | 0.1013 |
Echinococcus granulosus | phosphatidylinositol 4 phosphate 3 kinase C2 | 0.0063 | 0.0621 | 0.038 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0675 | 1 | 1 |
Giardia lamblia | Kinase, CMGC MAPK | 0.0675 | 1 | 1 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0164 | 0.2163 | 0.2079 |
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.0675 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0178 | 0.0072 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.005 | 0.0412 | 0.0167 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0039 | 0.025 | 0.01 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.025 | 0.0145 |
Onchocerca volvulus | 0.0039 | 0.025 | 0.5 | |
Brugia malayi | phosphoinositide 3'-hydroxykinase p110-alpha subunit, putative | 0.0086 | 0.097 | 0.0832 |
Trichomonas vaginalis | phosphatidylinositol kinase, putative | 0.0098 | 0.1149 | 0.1013 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.0675 | 1 | 1 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0039 | 0.025 | 0.01 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0039 | 0.025 | 0.01 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.025 | 0.0145 |
Brugia malayi | beta-lactamase family protein | 0.0039 | 0.025 | 0.01 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.005 | 0.0412 | 0.0309 |
Entamoeba histolytica | hypothetical protein | 0.0078 | 0.0843 | 0.6931 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase 2, putative | 0.0098 | 0.1149 | 0.1053 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.025 | 0.0145 |
Echinococcus multilocularis | mitogen activated protein kinase | 0.0675 | 1 | 1 |
Giardia lamblia | Phosphoinositide-3-kinase, catalytic, alpha polypeptide | 0.0047 | 0.0373 | 0.0373 |
Trichomonas vaginalis | phopsphatidylinositol 3-kinase, drosophila, putative | 0.0098 | 0.1149 | 0.1013 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.005 | 0.0412 | 0.0167 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.0675 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -4.784 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.784 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.731 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.673 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.594 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.514 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.511 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.484 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.